NRD
EHC icon

Nebula Research & Development’s Encompass Health EHC Stock Holding History

Nebula Research & Development’s Portfolio EHC Stock Details EHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-12,635
Closed -$1.55M – 288
2025
Q2 		$1.55M Buy
+12,635
New +$1.44M 0.13% 256
2024
Q3 		– Sell
-15,975
Closed -$1.37M – 990
2024
Q2 		$1.37M Buy
+15,975
New +$1.34M 0.22% 137
2023
Q4 		– Sell
-3,593
Closed -$241K – 704
2023
Q3 		$241K Buy
+3,593
New +$247K 0.13% 346

Other funds holding EHC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nebula Research & Development's EHC Position: Q3 2025 in Review

Nebula Research & Development sold out of Encompass Health (EHC) in Q3 2025, closing a stake of 12,635 shares — an estimated $1.55M sold.

Nebula Research & Development first reported a position in EHC in Q3 2023 and held it in 3 quarters. The position peaked at $1.55M in Q2 2025. 604 funds tracked by Wall St. Rank hold EHC as of Q3 2025.

  • Nebula Research & Development reported no remaining Encompass Health position as of Q3 2025 after selling out during the quarter.
  • Nebula Research & Development sold 12,635 Encompass Health shares in Q3 2025, an estimated $1.55M.
  • Nebula Research & Development first reported a position in Encompass Health in Q3 2023 and held it in 3 quarters.
  • Nebula Research & Development's Encompass Health position peaked at $1.55M in Q2 2025.
  • 604 funds tracked by Wall St. Rank held Encompass Health as of Q3 2025.

Based on Nebula Research & Development's 13F filing for Q3 2025.